Objectives: This paper reports the psychometric properties of two new condition-specific questionnaires: 1) the 18-item ThyDQoL individualised measure of perceived impact of hypothyroidism on quality of life (QoL), and 2) the 15-item ThySRQ, in which patients rate symptom bother.
INTRODUCTION
Hypothyroidism (whereby the thyroid gland produces insufficient thyroid hormone) is a life-long chronic condition particularly prevalent in women and the elderly [1] . A recent large US survey found that 9.5% of the population had elevated serum levels (>5.1 mIU/L) of thyroid stimulating hormone (TSH), indicative of hypothyroidism (both clinical and subclinical) [2] . The disorder slows the metabolism, with classic symptoms of slowness of movement, tiredness, low energy, change in appearance and voice, weight gain, cold intolerance, poor libido and constipation. Neuromuscular symptoms such as muscle stiffness, cramps and easy fatigability are common. There may be cognitive problems including poor memory, attention deficits, difficulties with calculations, and slow reaction times. Hypothyroidism is also associated with high psychiatric morbidity, in particular depression and paranoid disorder [3] .
The multiple aversive symptoms of hypothyroidism, both physiological and psychological, can have a considerable effect on quality of life (QoL). There is currently controversy about appropriate levels of thyroid hormone replacement, and greater understanding is needed for the reasons why some patients feel far from well on thyroid hormone replacement dosage that meets current guidelines [4] .
However, psychosocial aspects have hitherto received less attention than clinical aspects [5] , and multidimensional assessments of patient-reported outcomes are now needed for clinical trials and routine clinical use with individual hypothyroid patients. A new condition-specific, individualised questionnaire, the Underactive Thyroid-Dependent Quality of Life Questionnaire (ThyDQoL), has recently been designed [6] to measure the impact of hypothyroidism on different aspects of life. The present paper concerns the evaluation of this questionnaire's psychometric properties.
We also introduce a new self-completion measure of symptoms in hypothyroidism, the Underactive Thyroid Symptom Rating Questionnaire (ThySRQ), which assesses the degree to which patients are bothered by applicable symptoms. The ThySRQ was designed simultaneously with the ThyDQoL in interviews with patients [6] , but hitherto has not been reported. There are instruments in place for the diagnosis of hypothyroidism on the basis of symptoms [7, 8] but they are for completion by health professionals. Other symptom measures exist [9] [10] [11] [12] [13] [14] , usually designed specifically for a clinical trial [12] [13] [14] [15] , but which do not appear to have been validated psychometrically, or designed on the basis of interviews with patients. Although patients were involved in the identification of important symptoms in the development of the Chronic Thyroid Questionnaire [11] , the measure itself does not appear to have undergone validation for completion by patients. Measures of symptom frequency or relative change [12, 13, 15] are not tapping how much 'bothered' a patient is by a symptom: a symptom might occur frequently, but not trouble the patient unduly and vice versa. There is a need for a short, validated self-completion measure of the most common hypothyroid symptoms that has been developed through interviews with patients. The present paper reports the validation of the new ThySRQ measure of perceived symptom severity and the evaluation of its psychometric properties.
METHODS
In this cross-sectional study, hypothyroid patients completed the ThyDQoL and ThySRQ instruments.
Forty-seven patients were recruited from the diabetes and endocrinology clinic at Queen Elizabeth Hospital, Gateshead, UK (5% of whom were attending the hospital for their primary hypothyroidism, the remainder for other endocrine conditions including diabetes or secondary hypothyroidism, and some had developed hypothyroidism following treatment of hyperthyroidism and thus they did not have primary hypothyroidism). Sixty-three of the sample were recruited from three local primary care practices in which all patients were approached who fitted the inclusion criteria. The reasons patients were recruited from primary care as well as from a hospital setting were that a) people referred to hospital may have a more severe form of disease, and b) hypothyroidism is primarily managed in primary care and the vast majority of patients are seen there. Thus, combining the two would give a sample that included a substantial number of patients representative of those treated in primary care, as well as ensuring that more severely affected patients were included. The age range was 18+ years (no upper limit), and all patients had a diagnosis of hypothyroidism based on two blood tests taken at least three months apart. People known to have mental health problems likely to render them incapable of understanding and completing the questionnaires were not included. The Gateshead Local Research Ethics Committee gave approval for the research, which was carried out in compliance with the Helsinki declaration.
The ThyDQoL items are not weighted by importance ratings, but QII, Thyroid-dependent QoL, is scored in the same way as the domains, from -3 to +1. QI, Present QoL, however, is scored +3 to -3 from excellent to extremely bad, so that a higher score indicates better QoL.
Respondents may also indicate any other ways in which they perceive hypothyroidism to affect their QoL in a 'free comments' section at the end of the questionnaire. This allows for the addition of further domains to the questionnaire in the future, if required, as part of its continuing development. been found, during interviews or in questionnaire development work, to be interpreted as meaning the past three to six weeks. Although it would be possible to specify a time period (e.g. the past four weeks), in practice patients are not able to remember so precisely when symptoms occur and such specificity may give an illusion of precision that does not exist.
Statistical Analyses
Normality of distributions was determined through investigation of histograms and z (skew) scores (comparing the skewness value with zero using the z distribution), where z (skew) scores between ±2.58 are indicative of normality [24] .
No data from respondents selecting a N/A response option on the ThyDQoL would normally be consistency reliability was taken as 0.8 [25] and acceptable corrected item-total correlations were >0.2 [26] . To assess the effects of missing domain data (impact or importance ratings) on the reliability of the ThyDQoL, reliability analyses were run sequentially, deleting the strongest item each time, (i.e.
deleting the item having the lowest 'alpha if item deleted' and therefore contributing most to the scale's internal reliability) [27] . Factor structure was explored using Principal Components as an extraction method with Varimax rotation. Loadings greater than 0.3 are, by convention, considered salient and one of 0.6 is considered high [28] but salient loadings were here taken as ≥0.4 to ensure findings were robust. Correlations between questionnaire variables were explored using Pearson's r and Spearman's rho for parametric and non-parametric data respectively.
Construct validity was not specifically assessed, as there were no a priori hypotheses about strength or direction of correlations or subgroup differences in relation to biomedical variables. Sub-group analyses were nevertheless undertaken and explored differences in treatment and degree of hypothyroidism (subclinical vs. overt) using t-tests or Mann-Whitney tests for parametric and nonparametric data respectively, and differences in TSH level (within the reference range, above or below this range) using Univariate Analysis of Variance. Two-tailed significance was applied throughout. To reduce Type 1 error, the Holm's sequential Bonferroni procedure for multiple tests [29] was applied whereby the number of multiple tests divides alpha, but the denominator decreases by one for each significant result.
Initial Analyses To Determine Whether The Four Recruitment Samples Could Be Combined.
There is a possibility that subgroup differences associated with data from the four recruitment sources might create artifactual correlations in the combined sample, if the subgroup mean scores differed consistently across items. This was investigated by converting the scores to standardised z-scores within each subgroup before combining the sub-sets of scores. Such standardisation renders group means identical and thereby removes the possibility of correlations caused by subgroup differences (a method adopted when developing the ADDQoL [16] ). Forced one-factor solutions on the raw scores, and then on the z-scores, produced two sets of factor loadings that were then compared using correlation and regression analyses. There was no significant difference between loadings of standardised and raw scores: the correlation of 0.998 was close to 1, the constant was 0.0, and the slope of the regression line (1.001) did not differ significantly from 1, [t (15) = 60.28, p >0.05]. Thus, initial analyses demonstrated that the four recruitment groups could be treated as one sample for reliability and factor analyses (for which a larger N is desirable).
RESULTS

The Study Sample And Questionnaire Completion Rates
Of the 128 patients invited to complete the ThyDQoL and ThySRQ, 110 accepted and returned completed questionnaires (participation rates of 90% and 83% at the hospital clinic and primary care respectively). The characteristics (ethnicity and age) of responders were similar to non-responders, but there was a significant sex difference (p = 0.042), as the ratio of non-responders to responders was 0:21 (men) but 18:89 (women). There were four sources of recruitment: hospital clinic (47 patients), and three primary care practices, providing 9, 6, and 48 patients respectively. The mean age of the sample was 55.1 years, and mean duration of hypothyroidism was 8.3 years. The ratio of women to men was 9:2, similar to the sex ratio of thyroid disease found in the general US population in a recent study [30] . The great majority of patients had autoimmune hypothyroidism (N = 98, 89%) of whom 11 patients had subclinical hypothyroidism. The great majority (N = 103, 94%) were receiving thyroxine replacement. Measurements of TSH levels were available for 95 patients (86%) (median 2.4 mu/L), but in the case of free thyroxine (FT4) only 49 patients (45%) (mean 17.4 pmol/L). See Table 2 .
Healthcare professionals prompted patients recruited at the hospital to complete any missed items, however, completion rates for the 63 questionnaire sets collected at the primary care clinics (where patients were not prompted) were: 1) ThyDQoL: impact ratings (98.5%), importance ratings (98.1%).
The data from two patients (one from the hospital clinic and the other from primary care) were to +3) ( Table 1 ). The majority of respondents (71%) perceived that hypothyroidism had had a negative impact on overall QoL (mean QII, Thyroid-dependent QoL, was -1.25), and QI, Present QoL, was rated as between good and neither good nor bad (mean 0.89) ( sufficiently high for QII to replace the full ThyDQoL for some purposes. There were no a priori hypotheses regarding any subgroup differences, and the study was not powered to detect any, and indeed no significant treatment sub-group differences were found. However, it is interesting to note Twenty-two patients responded in the free comments section but when their comments were analysed, it was found that they were expanding on their responses to existing questionnaire domains, or were referring to aspects of symptoms or treatment covered in the ThySRQ or the Underactive Thyroid Treatment Satisfaction Questionnaire [6] respectively. No new domains were indicated.
ThySRQ
The most common reported symptoms were tiredness (90% of respondents), feeling depressed or low, and skin problems ( Table 4 ). The mean number of symptoms reported per patient was 7.4 (3.2), N = 107, with six patients indicating they had 13 or more symptoms. Almost one third reported being very much bothered by symptoms of tiredness, weight gain or depression when applicable. The highest mean bother ratings were for hair, weight gain, depressed, and cold. When data were examined from the 57 respondents who had either no comorbidities (N = 42), or whose only comorbidities were likely to be perceived by patients as symptomless (hypertension and hypercholesterolaemia, N = 15), the picture was only a little different: the most common reported symptoms were tiredness, depression, problems with concentration and skin, weight gain, memory and cold (full results not reported).
Exploratory psychometric analyses were performed on the ThySRQ scale formed by the 15 symptom bother ratings although the questionnaire, being a number of disparate symptoms, was not expected to have high internal consistency reliability or any particular factor structure. ThySRQ internal consistency reliability was unexpectedly high: Cronbach's alpha = 0.808, standardised alpha = 0.81, N = 95, with all corrected item-total correlations >0.2. Only two items would increase alpha if deleted from the scale (items 5, hair and 9, hearing), and by no more than 0.002 (full results not shown).
Results of unforced and forced factor analyses were unclear, with insufficient evidence of satisfactory subgroups of symptoms that could produce reliable subscale scores. Forced 1-factor analyses showed 12/15 items loading >0.44 but constipation, hair and hearing fell short of this (0.35 to 0.28)
indicating that a total score is not fully justified. This result was not unexpected.
Chi-Square tests found no significant differences in symptom frequency of thyroxine-treated and untreated patients nor were significant correlations found between TSH (a tissue marker for severity of hypothyroidism) and ThySRQ bother ratings, once the Bonferroni correction had been applied.
Relationships Between The ThySRQ And ThyDQoL Questionnaires
When both ThyDQoL and ThySRQ questionnaires are administered to patients it would be prudent, if
analysing relationships between ThyDQoL AWI and ThySRQ symptom bother ratings, to exclude patients' responses to the four ThyDQoL symptom domains (energy, weight, bodily discomfort and depression) from the calculation of the AWI score, i.e. a maximum of 14 items should be included in the AWI-14 score. Analyses showed a very high internal consistency reliability of the 14-item ThyDQoL (Cronbach's alpha = 0.944, N = 99), with lowest corrected item-total correlation of 0.57. All loadings on a forced 1-factor analysis were >0.6. This provided evidence for the reliability and validity of calculating overall AWI-14. Mean ThyDQoL AWI-14 for the sample was -2.86 (2.22), slightly less negative than -3.11 (2.2) for the full 18-item AWI-18, as expected.
When correlating AWI-14 with ThySRQ bother ratings, the strongest significant negative correlations were found (in decreasing order) with tiredness, concentration, depressed, weight gain, cold, speech and skin ( Table 5 ), indicating that increased symptom bother was associated with greater negative impact of hypothyroidism on QoL. The correlations with AWI-14 were very similar to those with the full 18-item ThyDQoL AWI-18, (Table 5) 
DISCUSSION
The ThyDQoL is a new individualised measure of the perceived impact of hypothyroidism on QoL, with high completion rates indicating good acceptability to respondents. Internal consistency reliability was excellent and factor analyses highly supportive of the combination of all 18 weighted domains into a single average score, the ThyDQoL AWI-18 score, which indicated moderately severe perceived negative impact of hypothyroidism on QoL in this sample. Useful information can be elicited from the single overview items. On average, respondents' present QoL (QI) was perceived to be between good and neither good nor bad and QII, concerning impact of hypothyroidism on QoL, could provide an approximate substitute for the full ThyDQoL for some purposes, (e.g. when respondent burden is of particular concern), as the correlation between QII and overall ThyDQoL AWI-18 was high (r = 0.69).
Analysing individual domains separately can provide rich information. For example, we found that, despite most patients receiving thyroxine replacement to normalise TSH levels, hypothyroidism still had a marked negative impact, particularly on motivation, weight, feelings of depression, bodily discomfort and energy, which may well impact on several other domains, such as spare-time activities or work. Over 70% of respondents reported feeling depressed or having bodily discomfort in recent weeks. Content validity was supported, as no new ThyDQoL domains emerged when analysing the free comments section, and all existing domains detected negative impact of hypothyroidism, with mean weighted domain impact scores of -2 or less, as shown in Table 1 .
The new Underactive Thyroid Symptom Rating Questionnaire measures both symptom frequency and the degree to which patients are bothered by symptoms associated with hypothyroidism. All 15 symptoms were experienced recently by at least some patients and there was a wide spread of frequencies of responses from not at all bothered to very much bothered. Internal consistency reliability was unexpectedly high, but factor analysis did not support the calculation of a total symptom bother score. Analysis of the most frequently reported symptoms (tiredness, depression, weight gain, and problems with skin, concentration and memory) and bother ratings, confirmed the typical picture of hypothyroidism: physiological symptoms connected with slowing of the metabolism and also reduced psychological well-being and impaired cognitive functioning. Although measures of health status are often and erroneously described as QoL measures [31, 32] , in this study symptoms (an aspect of health status) and QoL were distinct and separate patient-reported outcomes, as indicated by low to moderate correlations between symptom bother ratings and ThyDQoL AWI.
The ThyDQoL includes four symptom items that are also covered on the ThySRQ symptom measure, namely energy, weight, bodily discomfort and depression. We recommend that these four items be excluded from the calculation of ThyDQoL AWI when the questionnaire is administered with the ThySRQ, to avoid duplication and spurious correlations between the two questionnaires. The equivalent symptoms on the ThySRQ (tiredness, depressed, weight gain and cold) still had some of the strongest correlations with AWI-14, suggesting that the impact of those symptoms on QoL is reflected in ratings of many domains, and symptom-specific domains are not required in the ThyDQoL, although they are likely to increase face and content validity where no symptom measure is used. If troublesome symptoms can be reduced, QoL of patients may be improved [33] . The data suggested that patients were most bothered by hair problems, weight gain, depression, feeling cold, and tiredness and, of these symptoms, depression, feeling cold and tiredness were significantly correlated with ratings of present QoL. An optimal strategy for treating individual patients may be to identify individual patients' most bothersome symptoms using the ThySRQ and the impact of hypothyroidism on their QoL using the ThyDQoL and target efforts according to an individual's needs and priorities.
However, in order to improve the QoL of their patients in general, the present results suggest that healthcare professionals could most usefully direct their efforts to alleviating the symptoms of depression, feeling cold and tiredness. Symptoms can be selected for the ThySRQ to suit the purposes of a particular clinical trial. Further symptoms may need to be added if required (e.g. side effects of a new drug under evaluation), although the rationale of any deletions or additions would need to be justified.
One limitation of the study was that only two patients were recruited from ethnic minorities, although the incidence of hypothyroidism is similar in Whites and Asians but lower in Afro-Caribbeans. While the clinical manifestation of hypothyroidism would be expected to be similar for all ethnic groups, it is possible that different ethnic groups have varying perceptions of the effects of the disorder on their QoL, or they might be bothered to varying degrees by the symptoms, but this study was not designed to obtain data of this nature.
CONCLUSIONS
The ThyDQoL and ThySRQ are two new condition-specific questionnaires measuring the perceived impact of hypothyroidism on QoL, and bother ratings for 15 symptoms respectively, and allowing multidimensional assessments of the effects of treatment for hypothyroidism. Both questionnaires are performing well with good acceptability to the great majority of respondents. The ThyDQoL has excellent internal consistency reliability, domains can be analysed separately if required, and an overall score calculated. Additional symptoms may be added to the ThySRQ to suit the requirements of different studies. Sensitivity to change of both measures now needs to be evaluated in clinical trials. BMI: body mass index; TSH: thyroid stimulating hormone; FT4: free thyroxine. *Subclinical hypothyroidism defined as TSH level> 4mu/L and FT4 level in normal range (9 to 25 pmol/L) [34] . †All with subclinical hypothyroidism. The following comorbid conditions occurred: hypertension (26 patients), osteoarthritis (10), ischaemic heart disease (9), asthma (8), Type II diabetes (8), rheumatic disorder (7), hypercholesterolaemia (6), Type I diabetes (6), cancer (4), pregnancy (4), depression (4), Addison's disease (3), pernicious anaemia (3), coeliac disease (2) . Any other disorders were present in a maximum of one patient and are not reported. Several patients had multiple comorbid conditions. 
